首页> 外文期刊>Breast care >Early Breast Cancer Precursor Lesions:Lessons Learned from Molecular and Clinical Studies
【24h】

Early Breast Cancer Precursor Lesions:Lessons Learned from Molecular and Clinical Studies

机译:早期乳腺癌前体病变:分子和临床研究的经验教训

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Atypical ductal hyperplasia (ADH), flat epithelial atypia (FEA), and lobular neoplasia (LN) form a group of early precursor lesions that are part of the low-grade pathway in breast cancer development. This concept implies that the neoplastic disease process begins at a stage much earlier than in situ carcinoma. We have performed a review of the published literature for the upgrade risk to ductal carcinoma in situ or invasive carcinoma in open biopsy after a diagnosis of ADH, FEA, or LN in core needle biopsy. This has revealed the highest upgrade risk for ADH (28.2% after open biopsy), followed by LN (14.9%), and FEA (10.2%). With LN, the pleomorphic subtype is believed to confer a higher risk than classical LN. With all types of precursor lesions, careful attention must be paid to the clinicopathological correlation for the guidance of the clinical management. Follow-up biopsies are generally indicated in ADH, and if there is any radiological-pathological discrepancy, also in LN or FEA.
机译:非典型导管增生(ADH),扁平上皮非典型性增生(FEA)和小叶赘生物(LN)形成了一组早期前体病变,它们是乳腺癌发展中低级途径的一部分。该概念暗示肿瘤性疾病过程开始于比原位癌更早的阶段。我们对已发表的文献进行了回顾,分析了在核心穿刺活检中诊断为ADH,FEA或LN后,在开放活检中发生导管原位癌或浸润性癌的升级风险。这表明ADH的最高升级风险(开放活检后为28.2%),其次是LN(14.9%)和FEA(10.2%)。对于LN,据信多形亚型比经典LN具有更高的风险。对于所有类型的前体病变,必须仔细注意临床病理相关性,以指导临床管理。通常在ADH中进行随访活检,如果在放射病理学上存在差异,则也可以在LN或FEA中进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号